Attention deficit hyperactivity disorder (ADHD): review for primary care clinicians

Area of Science:

• Child and Adolescent Psychiatry
• Neurodevelopmental Disorders
• Pediatric Mental Health

Background:

• Attention deficit hyperactivity disorder (ADHD) affects up to 5% of primary school children, characterized by impulsivity, hyperactivity, and inattention.
• Genetic and environmental factors contribute to ADHD etiology, with untreated cases leading to poor long-term psychosocial outcomes.
• The Strengths and Difficulties Questionnaire (SDQ) can screen for ADHD and other psychiatric disorders in children.

Purpose of the Study:

• To outline current management strategies for Attention Deficit Hyperactivity Disorder (ADHD) in children.
• To emphasize the importance of integrated child mental health services.
• To advocate for systemic approaches and early intervention in ADHD treatment.

Main Methods:

• Review of current clinical guidelines, including National Institute for Health and Clinical Excellence (NICE) guidelines.
• Discussion of first-line pharmacological treatments (methylphenidate, atomoxetine).
• Inclusion of non-pharmacological interventions such as parent training and school-based programs.

Main Results:

• First-line treatments for ADHD include methylphenidate and atomoxetine.
• Parent training and school-based interventions are key components of management.
• Dedicated child mental health specialist services are crucial for optimal care.

Conclusions:

• Effective ADHD management requires adherence to NICE guidelines.
• Wider systemic approaches and early intervention are recommended to enhance treatment effectiveness.
• Integrated care combining medication, behavioral interventions, and specialist support is vital for children with ADHD.